美国成人造血细胞移植幸存者的疫苗犹豫与常规再接种:一项收敛混合方法分析
该研究采用横断面混合方法调查,纳入移植后2至8年的美国成人造血细胞移植幸存者,评估疫苗犹豫对再接种的影响。问卷应答率为30%,332名应答者中疫苗信心高、中、低分别占69%、20%和11%。混合分析显示疫苗信心量表得分与开放式回答一致,应开发针对疫苗犹豫幸存者的人群特异性干预措施并加以测试。
要点
- 332名成人HCT幸存者中,疫苗信心高占69%、中占20%、低占11%。
- 疫苗信心高的四因素包括民主党邮编区、自费支付再接种、移植前接种成人疫苗和接种COVID-19疫苗。
- 189名回答开放式问题的参与者中识别出14个与疫苗信心相关的主题,归为获益、危害、信任和其他4类。
核心结论
- 疫苗犹豫对美国成人HCT幸存者的再接种有影响,应开发并测试针对疫苗犹豫幸存者的人群特异性干预措施。
研究设计与样本
- 横断面混合方法调查研究,纳入移植后2至8年的美国成人HCT幸存者,使用疫苗信心量表(VCS)和开放式问卷条目。
- 问卷应答率为30%,共332名应答者。
主要发现
- 332名应答者中疫苗信心高占69%、中占20%、低占11%。
- 多变量分析显示与高疫苗信心相关的四因素为:民主党邮编区(按2020年选举结果)、自费支付再接种能力、移植前接种成人疫苗、接种COVID-19疫苗。
- 189名同时回答开放式条目的参与者中识别出14个与疫苗信心相关的主题,按VCS归为获益、危害、信任和其他4类。
- 合并分析显示VCS得分与开放式调查回答一致,并形成关于不同疫苗信心水平下再接种时各构念相对重要性的叙述。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Revaccination to restore immunity to vaccine-preventable diseases (VPDs) is essential risk mitigation in the prevention of infectious morbidity and mortality after hematopoietic cell transplantation (HCT). However, revaccination rates have been shown to be insufficient and to what extent vaccine hesitancy contributes to survivors not becoming fully revaccinated is unknown. We performed a cross-sectional, mixed methods survey-based study to explore how vaccine hesitancy influences revaccination among US adult HCT survivors who were 2 to 8 years after transplant. Participants were asked to complete the Vaccination Confidence Scale (VCS) and open-ended survey items regarding vaccine confidence. The survey response rate was 30 %; among 332 respondents, vaccine confidence was high in 69 %, medium in 20 %, and low in 11 %. On multivariable analysis, four factors associated with high vaccine confidence were: predominantly Democrat zip codes (per 2020 election results), ability to pay for revaccination out of pocket, receipt of pre-HCT adult vaccines, and receipt of COVID-19 vaccines. From 189 participants who also answered open-ended items, 14 themes associated with vaccine confidence were identified and collapsed into 4 categories based on the VCS: Benefits, Harms, Trust, and Other. Merged analysis showed congruence between VCS scores and open-ended survey responses and created a narrative about the relative importance of the constructs when approaching revaccination by vaccine confidence level. These findings significantly expand our knowledge of how vaccine hesitancy influences revaccination uptake among US adult HCT survivors. Population-specific interventions to approach vaccine-hesitant survivors should be developed and tested.
引用
- Wickline MM, Carpenter PA, Harris JR, et al. Vaccine hesitancy and routine revaccination among adult HCT survivors in the United States: A convergent mixed methods analysis. Vaccine. 2024. PMID: 39437647. doi:10.1016/j.vaccine.2024.126374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。